Recruitment

Recruitment Status
Completed
Estimated Enrollment
30

Inclusion Criterias

willing and able to provide informed consent
willing to participate in the guided and home Yoga practice
no active cancer
...
willing and able to provide informed consent
willing to participate in the guided and home Yoga practice
no active cancer
willing to drive to the study site
>3 months post-treatment of HNC
completed medically indicated physical therapy
medical clearance by study medical oncologist
>/= 18 years of age
ability to understand English in order to complete questionnaires

Exclusion Criterias

active Yoga practice within the past 6 months
medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia)
have received radiation therapy or chemotherapy for any condition other than primary HNC
...
active Yoga practice within the past 6 months
medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia)
have received radiation therapy or chemotherapy for any condition other than primary HNC
a prior cancer diagnosis within the past three years (except basal cell, surgically treated squamous cell skin cancer, early prostate cancer under observation)

Summary

Conditions
Head Neck Cancer
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Supportive Care

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

The use of aggressive treatment for head and neck cancer (HNC) particularly combined modality treatment regimens has resulted in an increase in survival. Unfortunately, this improvement has come with a marked increase in acute and late-effects. Acute HNC treatment-related toxicities have been clearl...

The use of aggressive treatment for head and neck cancer (HNC) particularly combined modality treatment regimens has resulted in an increase in survival. Unfortunately, this improvement has come with a marked increase in acute and late-effects. Acute HNC treatment-related toxicities have been clearly and extensively documented; however, data pertaining to adverse late-effects, those most likely to impact the survivor's long term symptom burden, functionality, and overall quality of life (QOL), are limited. This pilot study will be conducted to examine the feasibility of tailored Hatha Yoga as a therapeutic modality to address MSI in patients who have survived HNC.

Inclusion Criterias

willing and able to provide informed consent
willing to participate in the guided and home Yoga practice
no active cancer
...
willing and able to provide informed consent
willing to participate in the guided and home Yoga practice
no active cancer
willing to drive to the study site
>3 months post-treatment of HNC
completed medically indicated physical therapy
medical clearance by study medical oncologist
>/= 18 years of age
ability to understand English in order to complete questionnaires

Exclusion Criterias

active Yoga practice within the past 6 months
medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia)
have received radiation therapy or chemotherapy for any condition other than primary HNC
...
active Yoga practice within the past 6 months
medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia)
have received radiation therapy or chemotherapy for any condition other than primary HNC
a prior cancer diagnosis within the past three years (except basal cell, surgically treated squamous cell skin cancer, early prostate cancer under observation)

Locations

Nashville, Tennessee, 37232
Nashville, Tennessee, 37232
Nashville, Tennessee, 37232
Nashville, Tennessee, 37232

Tracking Information

NCT #
NCT01951664
Collaborators
  • National Institutes of Health (NIH)
  • National Cancer Institute (NCI)
Investigators
  • Principal Investigator: Sheila H Ridner, PhD, RN Vanderbilt University School of Nursing Principal Investigator: Barbara Murphy, MD Vanderbilt-Ingram Cancer Center
  • Sheila H Ridner, PhD, RN Vanderbilt University School of Nursing Principal Investigator: Barbara Murphy, MD Vanderbilt-Ingram Cancer Center